The price of Klotho Neurosciences Inc (NASDAQ:KLTO) shares last traded on Wall Street rose 122.46% to $0.29.
KLTO stock price is now 36.08% away from the 50-day moving average and -43.05% away from the 200-day moving average. The market capitalization of the company currently stands at $8.10M.
In other news, CHARDAN CAPITAL MARKETS LLC, 10% Owner sold 180,000 shares of the company’s stock on Jul 02 ’24. The stock was sold for $368,442 at an average price of $2.05. Upon completion of the transaction, the 10% Owner now directly owns 1,284,364 shares in the company, valued at $0.37 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 01 ’24, 10% Owner CHARDAN CAPITAL MARKETS LLC sold 115,136 shares of the business’s stock. A total of $237,618 was realized by selling the stock at an average price of $2.06. This leaves the insider owning 1,464,364 shares of the company worth $0.42 million. A total of 17.63% of the company’s stock is owned by insiders.
During the past 12 months, Klotho Neurosciences Inc has had a low of $0.11 and a high of $8.11. As of last week, the company has a debt-to-equity ratio of 0.23, a current ratio of 0.13, and a quick ratio of 0.13. The fifty day moving average price for KLTO is $0.21254 and a two-hundred day moving average price translates $0.5078 for the stock.
The latest earnings results from Klotho Neurosciences Inc (NASDAQ: KLTO) was released for 2024-12-31. The company reported revenue of $1.93 million for the quarter, compared to $62000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -3214.52 percent.
